Delivery Order SPE2DB20D1100-SPE2DB25FE0YN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Tivicay 50 mg tablets in quantities of 30, with a contract ceiling value of $23,342.52. This firm fixed-price delivery order, which is expected to be completed by August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order valued at $4,002.93 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Tivicay 50 mg tablets (30-count packages). The contract is a firm fixed-price delivery order with a completion date of September 10, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order represents a task order...
- The Defense Logistics Agency awarded a delivery order valued at $6,928.84 to AmerisourceBergen Drug Corp for Tivicay 50 mg tablets (30-count packages) on August 27, 2025, with completion scheduled for August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a single-item pharmaceutical procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this requirement...
- The Defense Logistics Agency awarded a delivery order valued at $2,277.11 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Tivicay 50 mg tablets (30-count units). This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under the company's existing contract vehicle. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This...
- The Defense Logistics Agency awarded a $4,002.93 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Tivicay 50 mg tablets (30-count packaging). This competitive award, with no set-aside designation, is a firm fixed-price contract that will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 17, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 tablets of Tivicay 50 mg with a ceiling value of $11,725.91. Issued on June 6, 2025, this firm fixed-price delivery order is set to be completed by June 9, 2025. The contract will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This award represents a competitive, non-set-aside procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $25,752.16 to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Tivicay 50 mg tablets (30-count packaging). This is a firm fixed-price, non-set-aside contract with performance completion scheduled for September 24, 2025, and fulfillment occurring at the vendor's headquarters in Conshohocken, Pennsylvania. Tivicay is an antiretroviral medication used in the treatment of HIV infection, representing the type of...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Tivicay 50 mg tablets (30-count units) under a firm fixed-price contract valued at $160,072.48, with completion scheduled for June 3, 2025. This non-set-aside award reflects competitive procurement practices and leverages AmerisourceBergen's established capability as a critical pharmaceutical distributor for federal medical needs. The delivery location is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count units) under a firm fixed-price contract structure. The award, issued on June 17, 2025, carries a ceiling value of $6,361.40 and requires completion by June 18, 2025. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania. This is a non-set-aside award issued through open competition, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Tivicay 50 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $4,178.97. This delivery order represents a non-set-aside award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle valued through December 2026. The place of performance is...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0YNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Tivicay 50 mg tablets (30-count package) with a ceiling value of $1,334.31. This firm fixed price delivery order, with an ultimate completion date of September 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation, and performance will occur at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive range of pharmaceutical products and medical supplies to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's extensive portfolio of DLA contracts demonstrates capability in delivering brand-name and generic medications across multiple therapeutic domains. This delivery order for Tivicay, an antiretroviral medication used in HIV treatment, aligns with the company's established role as a critical vendor for military and veteran healthcare pharmaceutical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/24/25 |